Roivant Sciences Ltd. (ROIV)
NASDAQ: ROIV · Real-Time Price · USD
21.53
-0.12 (-0.55%)
Feb 5, 2026, 12:40 PM EST - Market open
Roivant Sciences Market Cap
Roivant Sciences has a market cap or net worth of $14.97 billion as of February 5, 2026. Its market cap has increased by 82.52% in one year.
Market Cap
14.97B
Enterprise Value
10.77B
1-Year Change
82.52%
Ranking
Category
Stock Price
$21.53
Market Cap Chart
Since December 8, 2020, Roivant Sciences's market cap has increased from $533.38M to $14.97B, an increase of 2,707.39%. That is a compound annual growth rate of 90.80%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 4, 2026 | 15.06B | -0.23% |
| Dec 31, 2025 | 15.09B | 75.25% |
| Dec 31, 2024 | 8.61B | -4.61% |
| Dec 29, 2023 | 9.03B | 55.76% |
| Dec 30, 2022 | 5.80B | -18.13% |
| Dec 31, 2021 | 7.08B | 1,257.32% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 8, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Incyte | 20.14B |
| Genmab | 19.54B |
| Revolution Medicines | 18.66B |
| Moderna | 16.71B |
| BridgeBio Pharma | 14.49B |
| Ionis Pharmaceuticals | 13.77B |
| Ascendis Pharma | 13.49B |
| Exelixis | 11.48B |